The invention relates to ((phenyl)-3,6-dihydropyridin-1-yl) (bridged piperazinyl)-1-alkanone derivatives and ((phenyl)-2,5-dihydropyrrol-1-yl) (bridged piperazinyl)-1-alkanone derivatives, of general Formula (I)in which A, B, m, W, n and R5 are as defined in Claim 1, and also the process for the preparation thereof and the therapeutic use thereof.本發明係關於具有以下通式(I)之((苯基)-3,6-二氫吡啶-1-基)(橋聯哌基)-1-烷酮衍生物及((苯基)-2,5-二氫吡咯-1-基)(橋聯哌基)-1-烷酮衍生物:其中A、B、m、W、n及R5係如請求項1中所定義;且亦係關於其製備方法及其治療用途。